Trial of Indole-3-Carbinol and Silibinin

NCT03687073 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Smoking

Interventions

DRUG: Indole-3-Carbinol
DRUG: Silibinin
DRUG: Silibin

Sponsor

Masonic Cancer Center, University of Minnesota